Grifols signs 7-yr contract with Japan's Red Cross for $375 mln
MADRID, March 31
MADRID, March 31 (Reuters) - Spanish blood products company Grifols has signed a 7-year, $375-million contract to conduct blood analysis for Japan's Red Cross, the company said in a statement to the stock market regulator on Monday.
The contract to analyze 5.3 million blood transfusions a year for HIV and hepatitis and other infections was signed by Grifols unit Novartis Pharma, the Spanish group said.
Grifols acquired the blood transfusion testing unit of Novartis in January. (Reporting by Paul Day; Editing by Fiona Ortiz)
- Comedian Joan Rivers 'resting comfortably' at hospital |
- IBM launches Watson system for research, hopes for breakthroughs
- In town halls, U.S. lawmakers hear voter anger over illegal migrants |
- Separatists say will allow 'trapped' Ukrainian forces to withdraw |
- Obama says does not yet have broad strategy for Islamic State